| Product |
CAS |
More |
| PQR530 |
1927857-61-1 |
More |
| AZD-4635; HTL-1071 |
1321514-06-0 |
More |
| LX-2761 intermediate |
1219957-57-9 |
More |
| MSC2530818 |
1883423-59-3 |
More |
| Verucerfont; GSK561679; NBI77860 |
885220-61-1 |
More |
| MTX-211 |
1952236-05-3 |
More |
| MAK683 |
1951408-58-4 |
More |
| GSK-2018682 |
1034688-30-6 |
More |
| E-7046 |
1369489-71-3 |
More |
| PX-102; PX-20606 |
1268244-85-4 |
More |
| 7-benzocycloheptanone |
37949-03-4 |
More |
| CPI-444; V81444 |
1202402-40-1 |
More |
| Veliparib; ABT-888; NSC-737664 |
912445-05-7 (Veliparib Hydrochloride); 912444-00- |
More |
| Erlotinib Hydrochloride; Tarceva |
183319-69-9 (HCl), 183321-74-6 (free) |
More |
| Dacomitinib; PF-00299804; PF-299; PF-299804; PF-804; PF-0029 |
1042385-75-0 (Dacomitinib Monohydrate), 1110813-31 |
More |
| Neratinib; HKI-272; PB-272; PF-0528767; WAY-179272 |
698387-09-6 (free base); 915942-22-2 (Neratinib Ma |
More |
| Olmutinib; Olita |
1353550-13-6 |
More |
| Lapatinib Ditosylate Monohydrate |
388082-78-8(Lapatinib Ditosylate Monohydrate), 2 |
More |
| Vandetanib |
443913-73-3 |
More |
| Revefenacin; TD-4208; GSK-1160724 |
864750-70-9 |
More |
